Diastereomeric Salt Resolution Based Synthesis of LY503430, an AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Potentiator
This article describes the development and optimization of chemical reactions and subsequent preparation of the API LY503430 under cGMPs to fund first human dose (FHD) clinical evaluation as a potential therapeutic agent for Parkinson's disease. Reasons and rationale are presented for changes i...
Gespeichert in:
| Veröffentlicht in: | Organic process research & development 2005-09, Vol.9 (5), p.621-628 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 628 |
|---|---|
| container_issue | 5 |
| container_start_page | 621 |
| container_title | Organic process research & development |
| container_volume | 9 |
| creator | Magnus, Nicholas A Aikins, James A Cronin, Jason S Diseroad, William D Hargis, Amy D LeTourneau, Michael E Parker, Bruce E Reutzel-Edens, Susan M Schafer, John P Staszak, Michael A Stephenson, Gregory A Tameze, Shella L Zollars, Lisa M. H |
| description | This article describes the development and optimization of chemical reactions and subsequent preparation of the API LY503430 under cGMPs to fund first human dose (FHD) clinical evaluation as a potential therapeutic agent for Parkinson's disease. Reasons and rationale are presented for changes in solvents and reagents. One of the major developments presented here is the replacement of a chiral chromatography with a diastereomeric salt resolution. This article also discusses a preferred orientation issue with LY503430 which complicated the XRPD analysis. |
| doi_str_mv | 10.1021/op0500741 |
| format | Article |
| fullrecord | <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_op0500741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a954092017</sourcerecordid><originalsourceid>FETCH-LOGICAL-a325t-a3dfbecf187296c9c3b92f7467b3a99b16e91ffd80e90fccf31a0e6151f1bde33</originalsourceid><addsrcrecordid>eNptkM1KxDAUhYsoOI4ufINsBAeM3jRNf5Z1_IURB0dBVyVNEyZD25QkA1NfwOfxRXwmKyOu3NxzFx_nHE4QHBM4JxCSC9MBA0gishOMCAsBszR-3R1-SCmOSQz7wYFzKwBgMQlHwceV5s5LK00jrRZowWuPnqQz9dpr06JL7mSFFn3rl9Jph4xCszcGNKJwhniL8od5jk6_PnHe6NZgipd9Zc2mxww30i_7GkdYO7Ph76aWnTXdYDrE5EJXEzQ3XrZec2_sYbCneO3k0a-Og5eb6-fpHZ493t5P8xnmNGR-uJUqpVAkTcIsFpmgZRaqJIqTkvIsK0ksM6JUlYLMQAmhKOEgY8KIImUlKR0Hk62vsMY5K1XRWd1w2xcEip8Fi78FB_Zky3LhipVZ23Zo9g_3DZMmcKc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Diastereomeric Salt Resolution Based Synthesis of LY503430, an AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Potentiator</title><source>ACS Publications</source><creator>Magnus, Nicholas A ; Aikins, James A ; Cronin, Jason S ; Diseroad, William D ; Hargis, Amy D ; LeTourneau, Michael E ; Parker, Bruce E ; Reutzel-Edens, Susan M ; Schafer, John P ; Staszak, Michael A ; Stephenson, Gregory A ; Tameze, Shella L ; Zollars, Lisa M. H</creator><creatorcontrib>Magnus, Nicholas A ; Aikins, James A ; Cronin, Jason S ; Diseroad, William D ; Hargis, Amy D ; LeTourneau, Michael E ; Parker, Bruce E ; Reutzel-Edens, Susan M ; Schafer, John P ; Staszak, Michael A ; Stephenson, Gregory A ; Tameze, Shella L ; Zollars, Lisa M. H</creatorcontrib><description>This article describes the development and optimization of chemical reactions and subsequent preparation of the API LY503430 under cGMPs to fund first human dose (FHD) clinical evaluation as a potential therapeutic agent for Parkinson's disease. Reasons and rationale are presented for changes in solvents and reagents. One of the major developments presented here is the replacement of a chiral chromatography with a diastereomeric salt resolution. This article also discusses a preferred orientation issue with LY503430 which complicated the XRPD analysis.</description><identifier>ISSN: 1083-6160</identifier><identifier>EISSN: 1520-586X</identifier><identifier>DOI: 10.1021/op0500741</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Organic process research & development, 2005-09, Vol.9 (5), p.621-628</ispartof><rights>Copyright © 2005 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a325t-a3dfbecf187296c9c3b92f7467b3a99b16e91ffd80e90fccf31a0e6151f1bde33</citedby><cites>FETCH-LOGICAL-a325t-a3dfbecf187296c9c3b92f7467b3a99b16e91ffd80e90fccf31a0e6151f1bde33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/op0500741$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/op0500741$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids></links><search><creatorcontrib>Magnus, Nicholas A</creatorcontrib><creatorcontrib>Aikins, James A</creatorcontrib><creatorcontrib>Cronin, Jason S</creatorcontrib><creatorcontrib>Diseroad, William D</creatorcontrib><creatorcontrib>Hargis, Amy D</creatorcontrib><creatorcontrib>LeTourneau, Michael E</creatorcontrib><creatorcontrib>Parker, Bruce E</creatorcontrib><creatorcontrib>Reutzel-Edens, Susan M</creatorcontrib><creatorcontrib>Schafer, John P</creatorcontrib><creatorcontrib>Staszak, Michael A</creatorcontrib><creatorcontrib>Stephenson, Gregory A</creatorcontrib><creatorcontrib>Tameze, Shella L</creatorcontrib><creatorcontrib>Zollars, Lisa M. H</creatorcontrib><title>Diastereomeric Salt Resolution Based Synthesis of LY503430, an AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Potentiator</title><title>Organic process research & development</title><addtitle>Org. Process Res. Dev</addtitle><description>This article describes the development and optimization of chemical reactions and subsequent preparation of the API LY503430 under cGMPs to fund first human dose (FHD) clinical evaluation as a potential therapeutic agent for Parkinson's disease. Reasons and rationale are presented for changes in solvents and reagents. One of the major developments presented here is the replacement of a chiral chromatography with a diastereomeric salt resolution. This article also discusses a preferred orientation issue with LY503430 which complicated the XRPD analysis.</description><issn>1083-6160</issn><issn>1520-586X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNptkM1KxDAUhYsoOI4ufINsBAeM3jRNf5Z1_IURB0dBVyVNEyZD25QkA1NfwOfxRXwmKyOu3NxzFx_nHE4QHBM4JxCSC9MBA0gishOMCAsBszR-3R1-SCmOSQz7wYFzKwBgMQlHwceV5s5LK00jrRZowWuPnqQz9dpr06JL7mSFFn3rl9Jph4xCszcGNKJwhniL8od5jk6_PnHe6NZgipd9Zc2mxww30i_7GkdYO7Ph76aWnTXdYDrE5EJXEzQ3XrZec2_sYbCneO3k0a-Og5eb6-fpHZ493t5P8xnmNGR-uJUqpVAkTcIsFpmgZRaqJIqTkvIsK0ksM6JUlYLMQAmhKOEgY8KIImUlKR0Hk62vsMY5K1XRWd1w2xcEip8Fi78FB_Zky3LhipVZ23Zo9g_3DZMmcKc</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Magnus, Nicholas A</creator><creator>Aikins, James A</creator><creator>Cronin, Jason S</creator><creator>Diseroad, William D</creator><creator>Hargis, Amy D</creator><creator>LeTourneau, Michael E</creator><creator>Parker, Bruce E</creator><creator>Reutzel-Edens, Susan M</creator><creator>Schafer, John P</creator><creator>Staszak, Michael A</creator><creator>Stephenson, Gregory A</creator><creator>Tameze, Shella L</creator><creator>Zollars, Lisa M. H</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20050901</creationdate><title>Diastereomeric Salt Resolution Based Synthesis of LY503430, an AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Potentiator</title><author>Magnus, Nicholas A ; Aikins, James A ; Cronin, Jason S ; Diseroad, William D ; Hargis, Amy D ; LeTourneau, Michael E ; Parker, Bruce E ; Reutzel-Edens, Susan M ; Schafer, John P ; Staszak, Michael A ; Stephenson, Gregory A ; Tameze, Shella L ; Zollars, Lisa M. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a325t-a3dfbecf187296c9c3b92f7467b3a99b16e91ffd80e90fccf31a0e6151f1bde33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Magnus, Nicholas A</creatorcontrib><creatorcontrib>Aikins, James A</creatorcontrib><creatorcontrib>Cronin, Jason S</creatorcontrib><creatorcontrib>Diseroad, William D</creatorcontrib><creatorcontrib>Hargis, Amy D</creatorcontrib><creatorcontrib>LeTourneau, Michael E</creatorcontrib><creatorcontrib>Parker, Bruce E</creatorcontrib><creatorcontrib>Reutzel-Edens, Susan M</creatorcontrib><creatorcontrib>Schafer, John P</creatorcontrib><creatorcontrib>Staszak, Michael A</creatorcontrib><creatorcontrib>Stephenson, Gregory A</creatorcontrib><creatorcontrib>Tameze, Shella L</creatorcontrib><creatorcontrib>Zollars, Lisa M. H</creatorcontrib><collection>CrossRef</collection><jtitle>Organic process research & development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Magnus, Nicholas A</au><au>Aikins, James A</au><au>Cronin, Jason S</au><au>Diseroad, William D</au><au>Hargis, Amy D</au><au>LeTourneau, Michael E</au><au>Parker, Bruce E</au><au>Reutzel-Edens, Susan M</au><au>Schafer, John P</au><au>Staszak, Michael A</au><au>Stephenson, Gregory A</au><au>Tameze, Shella L</au><au>Zollars, Lisa M. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diastereomeric Salt Resolution Based Synthesis of LY503430, an AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Potentiator</atitle><jtitle>Organic process research & development</jtitle><addtitle>Org. Process Res. Dev</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>9</volume><issue>5</issue><spage>621</spage><epage>628</epage><pages>621-628</pages><issn>1083-6160</issn><eissn>1520-586X</eissn><abstract>This article describes the development and optimization of chemical reactions and subsequent preparation of the API LY503430 under cGMPs to fund first human dose (FHD) clinical evaluation as a potential therapeutic agent for Parkinson's disease. Reasons and rationale are presented for changes in solvents and reagents. One of the major developments presented here is the replacement of a chiral chromatography with a diastereomeric salt resolution. This article also discusses a preferred orientation issue with LY503430 which complicated the XRPD analysis.</abstract><pub>American Chemical Society</pub><doi>10.1021/op0500741</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1083-6160 |
| ispartof | Organic process research & development, 2005-09, Vol.9 (5), p.621-628 |
| issn | 1083-6160 1520-586X |
| language | eng |
| recordid | cdi_crossref_primary_10_1021_op0500741 |
| source | ACS Publications |
| title | Diastereomeric Salt Resolution Based Synthesis of LY503430, an AMPA (α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid) Potentiator |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T16%3A48%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diastereomeric%20Salt%20Resolution%20Based%20Synthesis%20of%20LY503430,%20an%20AMPA%20(%CE%B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%20Acid)%20Potentiator&rft.jtitle=Organic%20process%20research%20&%20development&rft.au=Magnus,%20Nicholas%20A&rft.date=2005-09-01&rft.volume=9&rft.issue=5&rft.spage=621&rft.epage=628&rft.pages=621-628&rft.issn=1083-6160&rft.eissn=1520-586X&rft_id=info:doi/10.1021/op0500741&rft_dat=%3Cacs_cross%3Ea954092017%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |